4.6 Article

In Vitro and In Vivo Antibacterial Activity, Toxicity and Resistance Analysis of Pleuromutilin Derivative Z33 against Methicillin-Resistant Staphylococcus aureus

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biochemistry & Molecular Biology

Antibacterial Activity of a Promising Antibacterial Agent: 22-(4-(2-(4-Nitrophenyl-piperazin-1-yl)-acetyl)-piperazin-1-yl)-22-deoxypleuromutilin

Xiang-Yi Zuo et al.

Summary: The novel pleuromutilin derivative NPDM exhibited excellent antibacterial activity against MRSA and showed low toxicity and good efficacy in mouse models, with rapid elimination in vivo.

MOLECULES (2021)

Review Chemistry, Medicinal

Penicillin binding protein 2a: An overview and a medicinal chemistry perspective

Menna-Allah W. Shalaby et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)

Review Biochemistry & Molecular Biology

Antibacterial properties and clinical potential of pleuromutilins

Olivia Goethe et al.

NATURAL PRODUCT REPORTS (2019)

Article Chemistry, Medicinal

Design, synthesis and biological evaluation of novel pleuromutilin derivatives possessing acetamine phenyl linker

Zhen Jin et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)

Review Pharmacology & Pharmacy

Pharmacogenomics of the cytochrome P450 2C family: impacts of amino acid variations on drug metabolism

Adriana Isvoran et al.

DRUG DISCOVERY TODAY (2017)

Article Multidisciplinary Sciences

Induced-fit tightens pleuromutilins binding to ribosomes and remote interactions enable their selectivity

Chen Davidovich et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)

Review Pharmacology & Pharmacy

MRSA - what is it and how do we deal with the problem?

JF Barrett

EXPERT OPINION ON THERAPEUTIC TARGETS (2005)

Article Pharmacology & Pharmacy

Highly selective inhibition of human CYP3A in vitro by azamulin and evidence that inhibition is irreversible

DM Stresser et al.

DRUG METABOLISM AND DISPOSITION (2004)